CompletedPhase 1NCT02594215
Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
Studying Proteus syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Human Genome Research Institute (NHGRI)
- Principal Investigator
- Leslie G Biesecker, M.D., MDNational Human Genome Research Institute (NHGRI)
- Intervention
- MK-7075 (miransertib)(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 6-65 years · All sexes
- Timeline
- 2015 – 2022
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02594215 on ClinicalTrials.govOther trials for Proteus syndrome
Additional recruiting or active studies for the same condition.